A recent report published by Infinium Global Research on microbiome sequencing services market provides an in-depth analysis of segments and sub-segments in the global as well as regional microbiome sequencing services market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional microbiome sequencing services market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global microbiome sequencing services market. According to the report, the global microbiome sequencing services market is projected to grow at a CAGR of 20.5% over the forecast period of 2018-2024.
A microbiome is the collection of trillions of microorganisms that live on and in an individual’s body. This microbiome lives on the skin, in the eyes, in the saliva & mouth, and rest of the gastrointestinal tract. The study of the microbiome is to understand the role of microbes in health and diseases. Microbiome plays an important role in human health, immunity, and metabolism. Slightly modification in the configuration of the microbiome can lead to diseases such as Crohn’s disease, asthma, cardiovascular diseases, and irritable bowel syndrome. Therefore, microbiome sequencing helps in understanding a wide range of diseases and treating them further.
Increasing demand for next-generation sequencing and increasing investment in microbiome research drive the market growth for microbiome sequencing services market. Further, growth in genomic research, drop in the cost of sequencing and flaring usage area of microbiome sequencing boost the growth of this market. Additionally, increasing consciousness regarding the benefits of the microbiome in cancer development is one of the key trend fueling the demand for microbiome sequencing services market. Increasing government funding and venture capitalist in research and development of pharmaceutical and biotechnology, companies lead the microbiome sequencing services. Rising occurrence of chronic diseases has produced plenty of opportunity for the growth of this market in an upcoming year. Whereas, the lack of professionals for interpreting data in this field is likely to restrain this market growth. This sequencing generates a massive amount of data that has to be construed using advanced software. Lack of knowledge for advanced tools of data analysis among professionals may restrain market growth.
Among the geographies, North America has accounted for the maximum share for microbiome sequencing services market. Factors such as ease in availability of commercial solutions for next-generation sequencing data analysis and government support with the help of funds for genomics research drive the market growth in the North America region. The Asia-Pacific is also projected to grow during the forecast period due to increasing demand for next-generation sequencing for diagnosis and the rising number of research studies.
The report on global microbiome sequencing services market covers segments such as technology, application, and end user. On the basis of technology, the sub-markets include sequencing by synthesis (SBS), sequencing by litigation (SBL), sanger sequencing, pyro sequencing, targeted gene sequencing, short gun sequencing, and ran sequencing. On the basis of application, the sub-markets include oncology, infectious diseases, gastro-intestinal diseases, and CNS diseases. On the basis of an end user, the sub-markets include pharmaceutical and biotechnology companies, and research and academic institutes.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in this region. The Asia-Pacific region offers substantial potential for the market growth owing to rapid growth in markets such as India and China.
The report provides profiles of the companies in the market such as uBiome, Inc., MR DNA, Microbiome Insights Inc., Merieux NutriSciences Corporations, BaseClear B.V., Zymo Research Corp., Second Genome, Microbiome Therapeutics, LLC, EpiBiome, and Clinical Microbiomics A/S.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of microbiome sequencing services market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter